Autoimmune polyendocrine syndrome: Difference between revisions
No edit summary |
|||
Line 35: | Line 35: | ||
==[[Autoimmune polyendocrine syndrome risk factors|Risk Factors]]== | ==[[Autoimmune polyendocrine syndrome risk factors|Risk Factors]]== | ||
==[[Autoimmune polyendocrine syndrome screening|Screening]]== | |||
==[[Autoimmune polyendocrine syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Autoimmune polyendocrine syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
Revision as of 12:35, 20 September 2012
For patient information click here
Autoimmune polyendocrine syndrome | |
ICD-10 | E31.0 |
---|---|
OMIM | 240300 269200 |
DiseasesDB | 29212 Template:DiseasesDB2 |
Autoimmune polyendocrine syndrome Microchapters |
Differentiating Autoimmune polyendocrine syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Autoimmune polyendocrine syndrome On the Web |
American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome |
Directions to Hospitals Treating Autoimmune polyendocrine syndrome |
Risk calculators and risk factors for Autoimmune polyendocrine syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune polyendocrine syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies